ACCUSIGN BZO-RAPID ONE-STEP BENZODIAZEPINE ASSAY

Enzyme Immunoassay, Benzodiazepine

PRINCETON BIOMEDITECH CORP.

The following data is part of a premarket notification filed by Princeton Biomeditech Corp. with the FDA for Accusign Bzo-rapid One-step Benzodiazepine Assay.

Pre-market Notification Details

Device IDK962672
510k NumberK962672
Device Name:ACCUSIGN BZO-RAPID ONE-STEP BENZODIAZEPINE ASSAY
ClassificationEnzyme Immunoassay, Benzodiazepine
Applicant PRINCETON BIOMEDITECH CORP. 4242 U.S. RT. 1 Monmouth Junction,  NJ  08852 -1905
ContactJemo Kang, Ph.d.
CorrespondentJemo Kang, Ph.d.
PRINCETON BIOMEDITECH CORP. 4242 U.S. RT. 1 Monmouth Junction,  NJ  08852 -1905
Product CodeJXM  
CFR Regulation Number862.3170 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1996-07-09
Decision Date1996-08-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.